Literature DB >> 28439178

Hispanic Residential Isolation, ADHD Diagnosis and Stimulant Treatment among Medicaid-Insured Youth.

Dinci Pennap1, Mehmet Burcu1, Daniel J Safer2, Julie M Zito3.   

Abstract

OBJECTIVE: This study aimed to evaluate a conceptual framework that assessed the effect of Hispanic residential isolation on Attention Deficit Hyperactivity Disorder (ADHD) health service utilization among 2.2 million publicly insured youth.
DESIGN: Cross-sectional.
SETTING: Medicaid administrative claims data for ambulatory care services from a US Pacific state linked with US census data. PARTICIPANTS: Youth, aged 2-17 years, continuously enrolled in 2009. MAIN OUTCOME MEASURES: The percent annual prevalence and odds of ADHD diagnosis and stimulant use according to two measures of racial/ethnic residential isolation: 1) the county-level Hispanic isolation index (HI) defined as the population density of Hispanic residents in relation to other racial/ethnic groups in a county (<.5; .5-.64; ≥.65); and 2) the proportion of Hispanic residents in a ZIP code tabulation area (<25%; 25%-50%; >50%).
RESULTS: Among the 47,364 youth with a clinician-reported ADHD diagnosis, 60% received a stimulant treatment (N = 28,334). As the county level HI increased, Hispanic residents of ethnically isolated locales were significantly less likely to receive an ADHD diagnosis (adjusted odds ratio [AOR]=.92 [95% CI=.88-.96]) and stimulant use (AOR=.61 [95% CI=.59-.64]) compared with Hispanic youth in less isolated areas. At the ZIP code level, a similar pattern of reduced ADHD diagnosis (AOR=.81 [95% CI=.77-.86]) and reduced stimulant use (AOR=.65 [95% CI=.61-.69]) was observed as Hispanic residential isolation increased from the least isolated to the most isolated ZIP code areas.
CONCLUSIONS: These findings highlight the opportunity for Big Data to advance mental health research on strategies to reduce racial/ethnic health disparities, particularly for poor and vulnerable youth. Further exploration of racial/ethnic residential isolation in other large data sources is needed to guide future policy development and to target culturally sensitive interventions.

Entities:  

Keywords:  ADHD; Hispanic Youth; Medicaid; Racial/ethnic Disparities; Residential Segregation; Stimulants

Mesh:

Year:  2017        PMID: 28439178      PMCID: PMC5398182          DOI: 10.18865/ed.27.2.85

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  26 in total

1.  Taking the measure of health care disparities.

Authors:  Margarita Alegria; Romana Hasnain-Wynia; John Z Ayanian
Journal:  Health Serv Res       Date:  2012-06       Impact factor: 3.402

2.  Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma.

Authors:  Timothy G Ferris; Karen Kuhlthau; John Ausiello; James Perrin; Robert Kahn
Journal:  Med Care       Date:  2006-01       Impact factor: 2.983

3.  Residential segregation, geographic proximity and type of services used: evidence for racial/ethnic disparities in mental health.

Authors:  Gniesha Y Dinwiddie; Darrell J Gaskin; Kitty S Chan; Janette Norrington; Rachel McCleary
Journal:  Soc Sci Med       Date:  2012-12-11       Impact factor: 4.634

4.  Do diabetic patients living in racially segregated neighborhoods experience different access and quality of care?

Authors:  Kitty S Chan; Darrell J Gaskin; Gniesha Y Dinwiddie; Rachael McCleary
Journal:  Med Care       Date:  2012-08       Impact factor: 2.983

5.  Toward a policy-relevant analysis of geographic and racial/ethnic disparities in child health.

Authors:  Dolores Acevedo-Garcia; Theresa L Osypuk; Nancy McArdle; David R Williams
Journal:  Health Aff (Millwood)       Date:  2008 Mar-Apr       Impact factor: 6.301

6.  Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample.

Authors:  Emily R Cox; Brenda R Motheral; Rochelle R Henderson; Doug Mager
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

7.  Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.

Authors:  Mehmet Burcu; Julie Magno Zito; Aloysius Ibe; Daniel J Safer
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-04-01       Impact factor: 2.576

8.  Geographic disparities in children's mental health care.

Authors:  Roland Sturm; Jeanne S Ringel; Tatiana Andreyeva
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

9.  Social and physical environments and disparities in risk for cardiovascular disease: the healthy environments partnership conceptual model.

Authors:  Amy J Schulz; Srimathi Kannan; J Timothy Dvonch; Barbara A Israel; Alex Allen; Sherman A James; James S House; James Lepkowski
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

10.  Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.

Authors:  Julie M Zito; Albert T Derivan; Christopher J Kratochvil; Daniel J Safer; Joerg M Fegert; Laurence L Greenhill
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-09-15       Impact factor: 3.033

View more
  2 in total

1.  Racial/ethnic segregation and health disparities: Future directions and opportunities.

Authors:  Tse-Chuan Yang; Kiwoong Park; Stephen A Matthews
Journal:  Sociol Compass       Date:  2020-04-05

2.  Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States.

Authors:  Sneha M Vaddadi; Nicholas J Czelatka; Belsy D Gutierrez; Bhumika C Maddineni; Kenneth L McCall; Brian J Piper
Journal:  PeerJ       Date:  2021-12-21       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.